Skip to main content
SpringerLink
Log in

Hepatocellular Carcinoma

  • Reference work entry
  • First Online:
Book cover Geriatric Diseases

  • 1559 Accesses

Abstract

Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide. Patients with hepatocellular carcinoma are at high risk of developing HCC. Risk factors for developing HCC include dietary aflatoxin (AFB1) ingestion, chronic alcoholism, chronic hepatitis virus (HBV, HCV) infections and hereditary conditions such as hereditary hemochromatosis. Hepatic carcinogenesis is a complex process and is associated with genetic and epigenetic changes, and different genes have been implicated in the pathogenesis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 379.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 379.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Rocken C, Carl-McGrath S. Pathology and pathogenesis of hepatocellular carcinoma. Dig Dis. 2001;19(4):269–78.

    Article  CAS  PubMed  Google Scholar 

  2. Dominguez-Malagon H, Gaytan-Graham. Hepatocellular carcinoma: an update. Ultrastruct Pathol 2001;25(6):497–516.

    Article  CAS  PubMed  Google Scholar 

  3. Mendizabal M, Reddy KR. Current management of hepatocellular carcinoma. Med Clin North Am 2009;93(4):885–900.

    Article  CAS  PubMed  Google Scholar 

  4. Forner A, Hessheimer AJ, Real MI, Bruix J. Treatment of hepatocellular carcinoma. Crit Rev Oncol Hamatol 2006;60(2):89–98.

    Article  Google Scholar 

  5. Chappel G, Kutanzi K, Uehara T, Tryndyak V, Hong HH, Hoenerhoff M, et al. Genetic and epigenetic changes in fibrosis-associated hepatocarcinogenesis in mice. Int J Cancer. 2014;134(12):2778–88.

    Article  Google Scholar 

  6. El-Serag HB. Hepatocellular carcinoma: an epidemiology view. J Clin Gastroenterol 2002;35(5):(suppl 2) S72–8.

    Article  PubMed  Google Scholar 

  7. Kudo M. The 2008 Okuda lecture: Management of hepatocellular carcinoma: from surveillance to molecular targeted therapy. J Gastroenterol Hepatol. 290;25(3):439–52.

    Google Scholar 

  8. Sanyal AJ, Yoon SK, Lencioni R. The etiology of hepatocellular carcinoma and consequences for treatment The Oncologist 2010;10(suppl 4):14–22.

    Article  Google Scholar 

  9. Xue KX. Molecular genetic and epigenetic mechanisms of hepatogenesis. Ai Zhng. 2005;24(6):757–68.

    CAS  Google Scholar 

  10. Tabor E. Hepatocarcinogenesis: hepatitis viruses and altered tumor suppressor gene function. Princess Takamatsu Symp. 1995;25:151–61.

    CAS  PubMed  Google Scholar 

  11. Nita ME, Alves AF, Carrilho FJ, Ono-Nita SK, de Mello ES, Gama-Rodrigues JJ. Molecular aspects of hepatic carcinogenesis. Rev Inst Med Trop S, Paulo. 2002; 44(1): https://doi.org/10.1590/S0036-4665200200010007.

  12. Cho YK, Kim JK, Kim WJ, Chug JW. Hepatic resection versus radiofrequency ablation for very early stage hepatocellular carcinoma: a Markov model analysis. Hepatology. 2010;51(4):1284–90.

    Article  PubMed  Google Scholar 

  13. Asahina Y, Tsuchiya K, Tamahi N, Hirayama I, Tanaka T, Sato M, et al. Effect of aging on risk of hepatocellular carcinoma in chronic hepatitis C virus infection. Hepatology. 2010;52:518–527.

    Article  CAS  PubMed  Google Scholar 

  14. Nordenstedt H, White DL, El-Serag HB. The changing pattern of epidemiology in hepatocellular carcinoma. Dig Liver Dis. 2010;42:S206–14.

    Article  PubMed  PubMed Central  Google Scholar 

  15. El-Serag HB, Rudolph KL. Hepatocellular carcinoma: Epidemiology and Molecular carcinogenesis. Gastroenterology. 2007;132:2557–2576.

    Article  CAS  PubMed  Google Scholar 

  16. Fung J, Lai CL, Yuen MF. Hepatitis B and C virus-related carcinogenesis. Clin Microbiol Infect. 2009;15(11):964–70.

    Article  CAS  PubMed  Google Scholar 

  17. Honda T, Miyaaki H, Ichikawa T, Taura N, Miuma S, Shibata H, et al. Clinical characteristics of hepatocellular carcinoma in elderly patients. Oncol Lett 2011;2(5):851–854.

    CAS  PubMed  PubMed Central  Google Scholar 

  18. Yeh CN, Lee WC, Jeg LB, Chen MF. Hepatic resection for hepatocellular carcinoma in elderly patients. Hepatogastroenterology. 2004;51(55):219–23.

    PubMed  Google Scholar 

  19. Reddy SK, Barbas AS, Turley RS, Gamblin TC, Gellen DA, Marsh JW, et al. Major liver resection in elderly patients: a multi-institutional analysis. J Am Coll Surg. 2011;21(5):787–95.

    Article  Google Scholar 

  20. Takenaka K, Shimada M, Higashi H, et al. Liver resection for hepatocellular carcinoma in the elderly. Arch Surg. 1994;129(8):846–50.

    Article  CAS  PubMed  Google Scholar 

  21. Singal A, Volk ML, Waljee A, Salgia R, Higgins P, Rogers MA, et al. Meta-analysis: surveillance with ultrasound for early stage hepatocellular carcinoma in patients with cirrhosis. Alim Pharmacol Ther. 2009;30:37–41.

    Article  CAS  Google Scholar 

  22. Lok AS, Sterling RK, Everhart JE, Wright EC, Hoefs JC, DiBisceglie AM, HALT – C Trial Group. et al. Des-gamma-carboxy prothrombin and alpha – fetoprotein biomarkers for early detection of hepatocellular carcinoma. Gastroenterology. 2010;138:493–50.

    Article  CAS  PubMed  Google Scholar 

  23. Bruix J, Sherman M. Management of hepatocellular carcinoma: An update. Hepatalogy. 2011;53(3):1020–1022.

    Article  Google Scholar 

  24. Bertino G, Neri S, Bruno CM, Ardne AM, Calvagno GS, Malaguanera M, et al. Diagnostic and prognostic value of alpha-fetoprotein, des-gamma-carboxy prothrombin and squamous cell carcinoma antigen immunoglobulin M complexes in hepatocellular carcinoma. Minerva Med. 201;102(5):363–71.

    Google Scholar 

  25. Forner A, Reig ME, deLope CS, Bruix J. Current strategy for staging and treatment: the BCLC update and future prospects. Semin Liver Dis. 2010;30:61–74.

    Article  CAS  PubMed  Google Scholar 

  26. Ng KK, Poon RT. Current treatment strategy for hepatocellular carcinoma. Saudi Med J. 2007;8(9):1330–8.

    Google Scholar 

  27. Choi JY. Treatment algorithm for intermediate and advanced stage hepatocellular carcinoma: Korea. Oncology. 2011;81 Suppl 1:141–146.

    Article  PubMed  Google Scholar 

  28. Borzio M, Dionigi E, Parisi G, Raguzzi I, Sacco R. Management of hepatocellular carcinoma I the elderly. World J Hepatol. 2015;7(11):1521–9.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Pugh RN, Murray-Lyon IM, Dawson JL, Pietrovic MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 173;60:646–9.

    Google Scholar 

  30. Sloss A, Kubler P. Prescribing in liver disease. Aust Prescr. 2009;32:32–5.

    Article  Google Scholar 

  31. Cabibbo G, Maida m, Camma C, Craxi A. Is efficacy of sorafenib treatment in patients with hepatocellular carcinoma affected by age? Expert Rev Anticancer Ther. 2013;13(12):1355–61.

    Article  CAS  PubMed  Google Scholar 

  32. Brunot A, Le Sourd S, Prachi M, Edelme J. Hepatocellular carcinoma in elderly patients; challenges and solutions. J Hepatocell Carcinoma. 2016;3:9–18.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Clegg A, Youg J, Iilffe S, Rikert MO, Rockwood K. Frailty in older people. Lancet 2013;381(9868):752–762.

    Article  PubMed  Google Scholar 

  34. Zhang W, Sun B. Impact of age on the survival of patients with liver cancer: an analysis of 27,255 patients on the SEER data base. Oncotarget 2015;(2):633–641.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The University of Sydney, Westmead Clinical School, Westmead, NSW, Australia

    Nages Nagaratnam & Kujan Nagaratnam

  2. Rehabilitation and Aged Care Service, Blacktown-Mt Druitt Hospital, Mount Druitt, NSW, Australia

    Gary Cheuk

Authors
  1. Nages Nagaratnam
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kujan Nagaratnam
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gary Cheuk
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Nagaratnam, N., Nagaratnam, K., Cheuk, G. (2018). Hepatocellular Carcinoma. In: Geriatric Diseases. Springer, Cham. https://doi.org/10.1007/978-3-319-33434-9_24

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-33434-9_24

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-33433-2

  • Online ISBN: 978-3-319-33434-9

  • eBook Packages: MedicineReference Module Medicine

Publish with us

Policies and ethics

Search

Navigation